Skin Cancer Champions. http://www.skincancerchampions.org
American Cancer Society. Basal and Squamous Cell Skin Cancer. https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer.html
Skin Cancer Foundation. Basal Cell Carcinoma Overview. https://www.skincancer.org/skin-cancer-information/basal-cell-carcinoma/
Memorial Sloan Kettering Cancer Center. Basal Cell Carcinoma. https://www.mskcc.org/cancer-care/types/basal-cell-carcinoma
American Academy of Dermatology. Skin Cancer Types. Basal Cell Carcinoma Overview. Last updated April 28, 2023. https://www.aad.org/public/diseases/skin-cancer/types/common/bcc
American Academy of Dermatology Association. Skin Cancer Types. Basal Cell Carcinoma Diagnosis and Treatment. https://www.aad.org/public/diseases/skin-cancer/types/common/bcc/treatment
National Comprehensive Cancer Network. NCCN Guidelines for Patients. Basal Cell Skin Cancer 2022. https://www.nccn.org/patients/guidelines/content/PDF/basal-cell-patient-guideline.pdf
Work Group; Invited Reviewers, Kim JYS, et al. Guidelines of care for the management of basal cell carcinoma. JÂ Amer Acad Derm. 2018;78:540-559. https://www.jaad.org/article/S0190-9622(17)32529-X/fulltext
NIH. National Cancer Institute. Skin Cancer Treatment (PDQ®)–Health Professional Version. Updated March 11, 2024. https://www.cancer.gov/types/skin/hp/skin-treatment-pdq
Bassett-Seguin N, Herms F. Update in the management of basal cell carcinoma. Acta Derm Venereol. 2020;100:adv00140. https://pubmed.ncbi.nlm.nih.gov/32346750/
Chen DS, Mellman I. Oncology meets immunology: The cancer-immunity cycle. Immunity. 2013;39:1-10. https://pubmed.ncbi.nlm.nih.gov/23890059/
Jayaraman SS, Rayhan DJ, , Hazany S, Kolodney MS. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol. 2014;134:213-220. https://pubmed.ncbi.nlm.nih.gov/23774526/
Kim DP, Bus KJB, Ruiz E. Basal cell carcinoma review. Hematol Oncol Clin North Am. 2019;33:13-24. https://pubmed.ncbi.nlm.nih.gov/30497670/
Lewis K, Perris K, Sekulic A, et al. Interim analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs). SKIN J Cutaneous Med. 2021;5:s3. https://jofskin.org/index.php/skin/article/view/1155
Morgan FC, Ruiz ES, KAria PS, et al. Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter. J Am Acad Dermatol. 2020;83:832-838. https://pubmed.ncbi.nlm.nih.gov/31600531/
Naik PP, Desai MB. Oncol Ther. Basal cell carcinoma: A narrative review on contemporary diagnosis and management. Oncol Ther. 2022;10:317-335. https://pubmed.ncbi.nlm.nih.gov/35729457/
Sekulic A, Migden MR, Lewis K, et al. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol. 2015;72:1021-1026.e8. https://pubmed.ncbi.nlm.nih.gov/25981002/
Villani A, Potestio L, Fabbrocini G, Scalvenzi M. New emerging treatment options for advanced basal cell carcinoma and squamous cell carcinoma. Adv Ther. 2022;39:1164-1178. https://pubmed.ncbi.nlm.nih.gov/35089534/
All URLs accessed June 24, 2024
